UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Customer-centric product presentations for monoclonal antibodies

AAPS open, 2023-01, Vol.9 (1), p.3-3, Article 3

Bittner, Beate

2023

Link zum Volltext

Verfügbarkeit prüfen

Formulation and Device Lifecycle Management of Biotherapeutics: A Guidance for Researchers and Drug Developers

1, 2022

Link zum Volltext

Verfügbarkeit prüfen

Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework

Expert opinion on drug delivery, 2023-04, Vol.20 (4), p.457-470

Bittner, Beate

2023

Link zum Volltext

Verfügbarkeit prüfen

Dispersive effects and focused biodistribution of recombinant human hyaluronidase PH20: A locally acting and transiently active permeation enhancer

PloS one, 2021-07, Vol.16 (7), p.e0254765-e0254765

2021

Link zum Volltext

Verfügbarkeit prüfen

Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2024-01, Vol.38 (1), p.23-46

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer

Journal of clinical pharmacology, 2013-02, Vol.53 (2), p.192-201

2013

Link zum Volltext

Verfügbarkeit prüfen

Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450

International journal of pharmaceutics, 2000-12, Vol.211 (1), p.89-92

2000

Link zum Volltext

Verfügbarkeit prüfen

Drug delivery breakthrough technologies – A perspective on clinical and societal impact

Journal of controlled release, 2023-08, Vol.360, p.335-343

2023

Link zum Volltext

Verfügbarkeit prüfen

Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release

Journal of controlled release, 1999-08, Vol.60 (2-3), p.297-309

1999

Link zum Volltext

Verfügbarkeit prüfen

Disease-Agnostic Electronic Adherence Aid for Subcutaneous at-Home and Self-Administration DevicesThe Lowest Common Denominator Based on a Cross-Indication Survey

ACS pharmacology & translational science, 2024-05, Vol.7 (5), p.1310-1319

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

Journal of clinical oncology, 2014-06, Vol.32 (17), p.1782-1791

2014

Link zum Volltext

Verfügbarkeit prüfen

Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting

Medical Devices : Evidence and Research, 2019-03, Vol.12, p.101-127

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20

International journal of clinical pharmacology and therapeutics, 2013-07, Vol.51 (7), p.537

2013

Link zum Volltext

Verfügbarkeit prüfen

Reply to: Letter to the editor "Subcutaneous herceptin therapy"

Journal of clinical pharmacology, 2013-12, Vol.53 (12), p.1343-1344

2013

Link zum Volltext

Verfügbarkeit prüfen

A Two-Stage Phase Ib Study to Investigate the Pharmacokinetics, Safety and Tolerability of Subcutaneous Rituximab In Patients with Follicular Lymphoma as Part of Maintenance Treatment

Blood, 2010-11, Vol.116 (21), p.2858-2858

2010

Link zum Volltext

Verfügbarkeit prüfen

Reply to: Letter to the editor “Subcutaneous herceptin therapy”: The Journal of Clinical Pharmacology

Journal of clinical pharmacology, 2013-12, Vol.53 (12), p.1343-1344

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC)

Pharmazie, 2012-03, Vol.67 (3), p.233-241

2012

Link zum Volltext

Verfügbarkeit prüfen